TY - JOUR AU - Lu, Xiaolin AU - Gu, Weijie AU - Shi, Guohai AU - Ye, Dingwei PY - 2021 TI - Pazopanib together with 6–8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma JF - Translational Andrology and Urology; Vol 10, No 5 (May 26, 2021): Translational Andrology and Urology Y2 - 2021 KW - N2 - UR - https://tau.amegroups.org/article/view/70141